Pharmaceuticals Funding This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

2013 Call for Nominations: Biochemical Engineering Journal Young Investigator Award
Closing date: March 31, 2013 The Biochemical Engineering Journal Young Investigator Award recognizes outstanding excellence in research and practice contributed to the field of biochemical engineering by a young community member. Candidates will be considered from all world regions, but must be less than 41 years of age on March 31, 2013. The Young Investigator Award is presented on an annual basis at either the Annual AIChE meeting in conjunction with the Food, Pharmaceutical and Bioengineering (FPBE) Division (even years) or ECI’s Biochemical and Molecular Engineering Conferences (odd years). The 201...
Source: ScanGrants feed - December 3, 2012 Category: Research Authors: Biochemical Engineering Journal Source Type: funding

Alzheimer's Disease Therapeutics Program (U01)
Funding Opportunity Number: RFA-AG-13-014 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.27393.85393.866Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) st...
Source: Grants.gov - November 1, 2012 Category: Research Tags: Health Source Type: funding

Alzheimer's Disease Therapeutics Program (U01)
Funding Opportunity RFA-AG-13-014 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to provide support for investigators to develop new drugs for the prevention or treatment of Alzheimers disease (AD). Specifically, this initiative is aimed at researchers who have promising small molecule compounds but lack outside drug development expertise and infrastructure support to advance these compounds to the clinic. This Alzheimers Disease Therapeutics Program adjunct to the NIH Blueprint Neurotherapeutics Program will allow investigators access to a virtual pharma network ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2012 Category: Research Source Type: funding

Healthy Living Grant Program: Prescription Medication Safety
The application deadline is July 16, 2012. This year's grants are supporting projects in the area of: Prescription Drug Safety Prescription Medication Safety, supported by an unrestricted grant from Purdue Pharma L.P.: Educational and awareness programs about the dangers of prescription drug abuse, targeted to children, parents or schools. In 2012, the Healthy Living Grant program will focus on medical-related organizations* and will encourage collaboration with nonprofits, schools or government entities. Grant of up to $8,000 will support approximately 25 projects addressing Prescription Medication Safety for...
Source: ScanGrants feed - May 17, 2012 Category: Research Authors: American Medical Association Foundation Source Type: funding

Academia-pharma collaboration attracts £14.4million funding in the UK to accelerate drug discovery
Medical Research Council (MRC) and the University of Dundee are pleased to announce new funding of over £14million for continuing research on the development of new drug treatments for major global diseases. (Source: Medical Research Council Funding News)
Source: Medical Research Council Funding News - May 16, 2012 Category: Research Source Type: funding

NIH Blueprint for Neuroscience Research Grand Challenge: Discovering Novel Drugs for Disorders of the Nervous System (U01)
Funding Opportunity RFA-NS-13-003 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) announces a unique opportunity for investigators working with small molecule compounds to gain access to a robust virtual pharma network to discover neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug discovery services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to conduct biological tes...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2012 Category: Research Source Type: funding

Dreifuss-Penry Epilepsy Award
Sponsored by the AAN and endowed by members of the AAN Epilepsy Section; Abbott Laboratories, Inc.; Cephalon, Inc.; Cyberonics, Inc.; Elan Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Neuroscience; Ortho-McNeil Neurologics; Pfizer Inc; Shire US, Inc; and UCB Pharma. This award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research. The award is named for two epileptologists who made outstanding contributions to the field of epilepsy. Presentation Recipient is expected to give a 10-minute presentation on a topic of their choice during a scientif...
Source: ScanGrants feed - August 21, 2011 Category: Research Authors: American Academy of Neurology Source Type: funding

NIH Blueprint for Neuroscience Research Grand Challenge: Developing Novel Drugs for Disorders of the Nervous System (U01)
Funding Opportunity RFA-NS-12-002 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) announces a unique opportunity for investigators working with small molecule compounds to gain access to a robust virtual pharma drug development network to develop neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug development services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to cond...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2011 Category: Research Source Type: funding

Call for Nominations: 2012 Thomas E. Starzl Prize in Surgery and Immunology
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2012 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation. The prize consists of a crystal award, an honorarium of $15,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2012 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. Over a two-day period, the winner will also participate in related activities and meet informally with faculty, post¬doctoral f...
Source: ScanGrants feed - February 1, 2011 Category: Research Authors: University of Pittsburgh Source Type: funding

Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases Joint Research Awards
Application Deadline: March 15, 2011 The IDSA Education and Research Foundation (ERF) and the National Foundation for Infectious Diseases (NFID) have joined forces to offer the IDSA ERF/NFID Joint Research Awards. Our goal is to support needed research by promising young researchers who may not otherwise find funding as federal and other institutional research support becomes more difficult to obtain. By co-sponsoring awards we hope to expand the awareness of our awards among the research community and attract the best possible candidates each year. If you have any questions, please contact Sharon Cooper-Kerr with N...
Source: ScanGrants feed - December 27, 2010 Category: Research Authors: Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases Source Type: funding

Dreifuss-Penry Epilepsy Award
Sponsored by the AAN and endowed by members of the AAN Epilepsy Section; Abbott Laboratories, Inc.; Cephalon, Inc.; Cyberonics, Inc.; Elan Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Neuroscience; Ortho-McNeil Neurologics; Pfizer Inc; Shire US, Inc; and UCB Pharma. This award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research. The award is named for two epileptologists who made outstanding contributions to the field of epilepsy. Presentation Recipient is expected to give a 10-minute presentation on a topic of their choice during a scientif...
Source: ScanGrants feed - September 27, 2010 Category: Research Authors: American Academy of Neurology Source Type: funding

Pharma-Nutrition 2011 Young Investigator Award
The Pharma-Nutrition 2011 programme will be featuring a Young Investigator Award which is designed to acknowledge research contributions that further the development and knowledge on the interface between nutrition and pharma. Criteria The award is open to all presenting authors under the age 35. The four criteria for judging are: * Originality of research concept. * Soundness of research design. * Quality/clarity of research report. * Perceived value of the research to Pharma-Nutrition. Selection Process From all eligible abstracts ten outstanding submissions will be nominated for the award. These selected...
Source: ScanGrants feed - September 24, 2010 Category: Research Authors: Pharma-Nutrition 2011 Source Type: funding

Nurse Practitioner Healthcare Foundation/Purdue Pharma L.P. Pain Management Awards
The Application deadline is November 8, 2010. Five (5) awards will be given to practicing nurse practitioners and graduate nurse practitioner students whose research or educational projects are related to pain management. Priority will be given to projects that target pain relief while avoiding misuse/abuse/diversion. Each recipient will receive an initial award of $3,500. Upon completion of the project, an additional $1,500 will be awarded to each recipient to support project dissemination (e.g. travel expenses for presenting at a regional/national meeting, editing a paper for publication; preparing a poster, etc.). ...
Source: ScanGrants feed - September 16, 2010 Category: Research Authors: Nurse Practitioner Healthcare Foundation/Purdue Pharma L.P. Source Type: funding

National Community Pharmacists Association Foundation Catalyst Grant Award Program
Purdue Pharma L.P. has awarded a grant to advance the National Community Pharmacists Association Foundation’s efforts to stimulate community-pharmacy based research that helps improve patient care and education. Purdue’s donation will support the NCPA Foundation’s Catalyst Grant Award Program for Innovative Practice, with a focus on pain management. Conducted over several years, this program will eventually generate a significant body of knowledge and evidence to highlight the effectiveness of pharmacy-provided services and the efficacy of pharmaceuticals when properly used. Each year, the selected b...
Source: ScanGrants feed - July 28, 2010 Category: Research Authors: National Community Pharmacists Association Foundation Source Type: funding

Society of Infectious Diseases Pharmacists/ASTELLAS Antifungal Research Award
The Society of Infectious Diseases Pharmacists (SIDP) is a dynamic association of health professionals dedicated to promoting the appropriate use of antimicrobials. SIDP is committed to excellence in infectious diseases education, pharmacotherapy, and research. One of the missions of SIDP is to promote research endeavors into the cause, prevention, and management of infectious diseases. Purpose: SIDP is soliciting proposals that focus on antifungal research from SIDP members. This grant seeks to foster research in the areas of fungal infections (unspecified) or antifungal pharmacotherapy. Funding: A grant in the amo...
Source: ScanGrants feed - June 25, 2010 Category: Research Authors: Society of Infectious Diseases Pharmacists/Astellas Pharma US, Inc. Source Type: funding

Purdue Partners Against Pain Award
Deadline: EXTENDED! May 28, 2010 Pain is just as much a symptom of any ailment, and just as deserving, if not more so, of devoted treatment. It is for this reason that the Purdue Partners Against Pain Award was established to reward excellence in the field of pain management. The recipient of this $10,000 award will be an osteopathic physician, center or program that has made great strides in field of pain research, management, or improving the quality of life for people living with acute and/or chronic pain. APPLICATION PACKETS MUST BE RECEIVED BY MAY 28, 2010. The 2010 recipient will be notified in July and wi...
Source: ScanGrants feed - May 16, 2010 Category: Research Authors: American Osteopathic Foundation/Purdue Pharma Source Type: funding

Conference Student Scholarships: Evolving Approaches to Early Stage Drug Discovery
Scholarship Deadline: December 2, 2010 (Midnight US Mountain Standard Time) This meeting will cover multiple aspects of the challenges and opportunities facing drug discovery scientists. These challenges include: 1) diverse approaches to early stage discovery in a resource constrained environment, 2) evolution of preclinical drug discovery in academia, 3) evolution of drug leads/target validation from the NIH (MLPCN), 4) funding early stage/risky programs, 5) external licensing of programs and 6) advances in biomarkers/imaging to enable target selection and rapid go/no go decisions. The meeting goals are to bring toge...
Source: ScanGrants feed - May 9, 2010 Category: Research Authors: Keystone Symposia Source Type: funding

Radiopharmaceutical Sciences Council Michael J. Welch Award
The Radiopharmaceutical Sciences Council (RPSC) is seeking nominations for the Michael J. Welch Award. The Welch Award was created as a means of recognizing individuals who have made an outstanding contribution to the field of radiopharmaceutical sciences. Although all individuals are eligible for this award, nominations will only be accepted from RPSC members. It is our intent to recognize individuals who have not received higher awards from the Society of Nuclear Medicine for their scientific contributions such as the Aebersold or de Hevesy Awards. Winners of the Berson-Yalow Award are eligible for the Welch Award. The ...
Source: ScanGrants feed - February 14, 2010 Category: Research Authors: Radiopharmaceutical Sciences Council Source Type: funding

2011 Thomas E. Starzl Prize in Surgery and Immunology
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2011 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation. The prize consists of a crystal award, an honorarium of $15,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2011 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. Over a two-day period, the winner will also participate in related activities and meet informally with faculty, postdoctoral fellows an...
Source: ScanGrants feed - February 2, 2010 Category: Research Authors: Thomas E. Starzl Transplantation Institute Source Type: funding

Dreifuss-Penry Epilepsy Award
Sponsored by the American Academy of Neurology and endowed by members of the AAN Epilepsy Section; Abbott Laboratories, Inc.; Cephalon, Inc.; Cyberonics, Inc.; Elan Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Neuroscience; Ortho-McNeil Neurologics; Pfizer Inc; Shire US, Inc; and UCB Pharma.This award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research. The award is named for two epileptologists who made outstanding contributions to the field of epilepsy.PresentationRecipient is expected to give a 10-minute presentation on a topic of their choice dur...
Source: ScanGrants feed - August 29, 2009 Category: Research Authors: American Academy of Neurology Source Type: funding

From Targets To Novel Drugs Initiative
Our company’s mission is to provide new treatment options for diseases with high unmet medical need. We are committed to innovation and to translating ideas from basic research into novel drugs. We are dedicated to fostering collaborations with excellent academic groups and start-ups. In order to further pool expertise and to join forces for mutual benefit, Bayer Schering Pharma AG intends to support collaborative research projects on attractive, novel molecular targets in the fields of * Oncology * Cardiology * Gynecology * In vivo ImagingTo promote this new approach, Bayer Schering Pharma AG intends to allocat...
Source: ScanGrants feed - July 23, 2009 Category: Research Authors: Bayer Schering Pharma AG Source Type: funding

American Nephrology Nurses' Association Watson Pharma, Inc. Career Mobility Scholarship
$2500 The application deadline is October 15, 2009 The purpose of Career Mobility Scholarships is to support qualified ANNA members in the pursuit of either BSN or advanced degrees in nursing that will enhance their nephrology nursing practice. Eligibility Criteria 1. Current full member of ANNA, having been a member for a minimum of the last 2 years as of the awards/scholarship application deadline date. 2. Accepted or enrolled in a baccalaureate or higher degree program in nursing. 3. Actively involved in nephrology nursing related health care services. 4. For NNCC scholarships only, the applicant must hold a curren...
Source: ScanGrants feed - May 24, 2009 Category: Research Authors: American Nephrology Nurses' Association Source Type: funding

American Nephrology Nurses' Association Nurse in Washington Internship Grants
Three grants - one each sponsored by ANNA, Watson Pharma, Inc., and Nursing Economic$, The Journal for Health Care Leaders The application deadline is November 15, 2009 PurposeTo support three qualified ANNA members to attend the annual Nurse in Washington Internship (NIWI) program held in Washington, DC, in March. Sponsored by the Nursing Organizations Alliance, the NIWI program provides nurses the opportunity to learn how to influence health care through the legislative and regulatory processes. Participants learn from health policy experts and government officials, network with other nurses, and visit members of Congre...
Source: ScanGrants feed - May 24, 2009 Category: Research Authors: American Nephrology Nurses' Association Source Type: funding

Trish Greene Research Grant--Oncology Nursing Research on Pain Assessment and Pain Management
Supported by Purdue Pharma LP. Award: One $10,000 grant. Purpose:To promote oncology nursing research in the areas of pain assessment and pain management. Note: If drug therapy is part of the research design, a Purdue Pharma, L.P. product must be used in at least one area of the treatments being employed. Application Deadline: November 1, 2009 Letters of Intent Due: October 1, 2009 Oncology Nursing Society Foundation 125 Enterprise Drive Pittsburgh, PA 15275 866-257-4ONS 412-859-6100 877-369-5497 (toll free fax) 412-859-6163 (fax) E-mail: foundation@ons.org Web site: www.onsfoundation.org (Source: ScanGrants feed)
Source: ScanGrants feed - April 13, 2009 Category: Research Authors: Oncology Nursing Society Foundation/Purdue Pharma LP Source Type: funding

Epilepsy Therapy Project - Matching Grants Towards the Commercialization of Promising Therapies
The Epilepsy Therapy Project - Matching Grants Towards the Commercialization of Promising Therapies Letter of Intent due: March 7, 2009 If the LOI is accepted, APPLICATION is due: April 22, 2009 by 11:59 PM The Epilepsy Therapy Project offers 1:1 matching grants of up to $100,000 to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. These matching funds seek to leverage other resources, and accelerate the pace of therapeutic advance. Proposals will be evaluated by our Scientific Advisory Board together with our Business Advisory Board. We seek to fund di...
Source: ScanGrants feed - December 16, 2008 Category: Research Authors: Epilepsy Therapy Project Source Type: funding

Bengt Magnusson Memorial Prize--Research Paper in Pedatric Dentistry
Bengt Magnusson Memorial Prize in Child Dental Health - 2009 This prize is awarded on alternate years at the Congress for the best submitted essay. Theessay must be an unpublished work and suitable for publication in the IJPD. The prize isawarded in the memory of Professor Bengt Magnusson of Goteberg, Sweden, a modernfounder of Paediatric Dentistry and a former member of the original IAPD until his death in1981.Sponsored by Omega Pharma Hellas S.A. RULES1. The name of the Prize is to be the Bengt Magnusson Memorial Prize in Child DentalHealth.2. The value of the Prize is to be € 1000 Euro.3. The Prize is open to all S...
Source: ScanGrants feed - December 14, 2008 Category: Research Authors: International Association of Paediatric Dentistry Source Type: funding